Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis
This study is currently recruiting participants.
Verified October 2010 by Lymphoma Study Association
Study NCT00553943
Information provided by Lymphoma Study Association
First Received on November 5, 2007.
Last Updated on October 22, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
